mogamulizumab

Spain

Drugs containing this active substance

  • POTELIGEO 4 MG/ML CONCENTRATE FOR INFUSION SOLUTION

    It is used to treat adults with cutaneous T-cell lymphoma types called mycosis fungoides and Sézary syndrome, in patients who have already received at least one prior systemic therapy (oral or injectable).

    Form: solution for infusion, concentrate

    Active substance Dosage
    mogamulizumab 20 mg

    ATC: L01F L01FX L01FX09

    Manufacturer: Kyowa Kirin Holdings B.V.